30 Mar 2022 Policy

One Cancer Voice 10-Year Cancer Plan Consensus Statement

Today, as one of 54 cancer charities, we speak with One Cancer Voice and publish 10 tests that the Government’s new 10-year Cancer Plan must meet if it is to be successful.

Drawing on our collective experiences from supporting people living with cancer, research, data and insight, we have developed this consensus statement, setting out what actions Government and the NHS need to take to ensure people diagnosed with cancer in England get the very best care and treatment.

If the new 10-year Cancer Plan is to be successful in delivering world leading and transformative change then we believe it must meet the following 10 tests:

1. The 10-year Cancer Plan has clear political leadership, is fully costed and funded throughout its lifetime, with an annual report published on progress made against its ambitions.

2. More cancers are prevented and England is ‘smoke free’ by 2030

3. The public is aware of the risk factors, signs and symptoms of cancer and act on them, leading to improvements in presentation. Emergency presentation is reduced to no more than 5%.

4. Progress towards early diagnosis is accelerated so that 78% of people are diagnosed at stage one or stage two and a 95% Faster Diagnosis Standard is met.

5. Every person with cancer can access the treatment they need, at the right time, for the best outcomes. Cancer Waiting Time targets are met in every part of the country.

6. By 2032, everyone with cancer is able to access a needs assessment and personalised care plan to support their health and wider wellbeing needs.

7. Workforce and equipment shortages are addressed so that every person with cancer has access to the specialist workforce they need when they need it.

8. Cases of cancer attributable to inequalities have meaningfully decreased.

9. Clinical research capacity is increased, health service staff have access to dedicated research time and training and all populations are given the opportunity to participate in clinical trials.

10. Data collection is timely, accessible, standardised and comprehensive and it is analysed and published swiftly to support the delivery and monitoring of all aspects of cancer across the pathway and cancer research.

There are around 313,000 new cancer cases in England every year, that’s around 858 people diagnosed every day (1). Cancer remains one of England’s biggest killers with 137,234 people dying of cancer in 2020 (2). This has increased by 8% since 2001 and will continue to increase as more people are diagnosed with the disease each year. (3)

This new Cancer Plan must be ambitious in scope to recover from the pandemic and to close the gap between England and the best performing countries in the world. The pandemic has affected cancer care, with an estimated 33,000 people missing from the system. Our survival continues to lag behind the best performing countries in the world. There is an urgent need to level up by focusing on inequalities across the cancer pathway so that everyone gets the very best cancer care.

1. Cancer Research UK – Cancer Incidence by sex and UK country

2. UK Parliament – Cancer statistics (England)

3. UK Parliament – Cancer statistics (England)

Related posts

Leukaemia: Investigating stem cells to prevent cancer

11 January 2019

Leukaemia: Investigating stem cells to prevent cancer

Dr Alice Giustacchini, University College London and John Goldman Fellow

Our life-saving work must continue

4 August 2020

Our life-saving work must continue

Leukaemia and other blood cancers don’t stop for coronavirus (COVID-19) and our vital research and care must continue

Can the unique differences between stem cells tell us how well CML treatment will work?

22 May 2023

Can the unique differences between stem cells tell us how well CML treatment will work?

What if we could predict how chronic myeloid leukaemia (CML) patients will respond to treatment? Could the unique signatures of CML stem cells hold the key to personalising treatment for…

John Goldman Fellowship awarded to Dr Pramila Krishnamurthy

29 November 2021

John Goldman Fellowship awarded to Dr Pramila Krishnamurthy

Leukaemia UK is proud to announce Dr Pramila Krishnamurthy of King’s College Hospital and King’s College London as a Leukaemia UK John Goldman Fellow co-funded by Rosetrees Trust. Dr Krishnamurthy will be using the fellowship to better understand why some leukaemia patients relapse following a stem cell transplant, and how donor lymphocyte infusion can help prevent this.